This programme receives the support of the Erasmus+ Programme of the European Union: a grant of € 2,410,000 was awarded to the LIVE consortium.
The Master LIVE (Erasmus+ Mundus Joint Master Degrees) offers an interesting multi- and inter-disciplinary academic programme in a very dynamic research area. The consortium involves a number of non-educational associated partners which are engaged with the programme delivery and management in a variety of activities. The Associate Partners from the whole vaccinology chain include SMEs, pharmaceutical organisations and large companies that cover all the different areas where graduate students can be employed. The industrial actors offer funding which strengthens the sustainability of the programme beyond EU funding. The proposal addresses current need of the society in preparing specialists in fundamental and applied aspects of vaccinology capable of continuing their career in academia or industry or healthcare sector.
MASTER LIVE WEBSITE : http://live.univ-lyon1.fr
Le parcours Master Erasmus+ Mundus BMC LIVE (Leading International Vaccinologie Education) est unique et financé par l’Europe. Enseigné en anglais, il accueille des étudiants scientifiques, vétérinaires, médecins ou pharmaciens de toute la planète, au moins diplômés d’une licence, pour les former successivement dans trois excellents centres universitaires européens : Barcelone, Anvers puis Lyon-St-Etienne. Enfin le stage du semestre 4 est réalisé chez nos partenaires internationaux. Ce parcours de deux ans confère 120 ECTS à l’issue d’une formation scientifique très solide en immunologie, immunopathologie, infectiologie, épidémiologie et vaccinologie, adossée à l’acquisition de compétences multilinguistiques et multidisciplinaires : législation, politique de santé, conduite de projet et sciences humaines en vaccinologie. Les étudiants sont formés à toutes les facettes de la chaîne de travail en vaccinologie : ses savoir-faire, ses fondements scientifiques, la recherche pour définir quand un vaccin est requis, le créer et le produire, les mesures de son efficacité, l’éthique et la communication, et enfin la connaissance personnalisée de la cinquantaine des principaux acteurs internationaux du domaine qui sont partenaires du Master. Il s’agit d’établissements de formation, de centres de recherches, de PME, de Pharma et d’organisations de la santé. Les étudiants vivent une formation d’excellente qualité très ouverte sur le monde pour que chacun devienne un cadre international en vaccinologie qui compte dans le domaine qui l’épanouit : académique (formation doctorale, enseignement supérieur), industriel (R&D, production, qualité, commercialisation), médical, vétérinaire, social avec la possibilité de passer de l’un à l’autre ou de coordonner leurs actions dans le cadre d’une politique.
Cette formation est dispensée exclusivement en anglais.
MASTER LIVE WEBSITE : http://live.univ-lyon1.fr
LIVE (Leading international vaccinology Education) Erasmus+ Mundus is a unique European Master in Vaccinology. LIVE organizes an integrated formation with a strong scientific background in Immunology, Infectiology, Vaccinology, but also multilingualism and multidisciplinarity: legislation, health policy and humanities around vaccinology. LIVE integrates know-how, know-what, know-why & know-who along the vaccinology chain: LIVE drives a very efficient and opened joint training between the academic and the industrial world to cover fundamental and translational research, industrial development and production, usage and epidemiological follow-up in vaccine clinical centres and communication.
International Manager in Vaccinology for quality control, commercial and business development, communication, public health, R & D, PhD training funded by Partners.
This training is only dispensed in English.
The LIVE students will be trained in Barcelona at semester 1 (S1) with the students registered at the national master called “Advanced Immunology”. The S1 programme is composed of a first specialisation in immunology and immunopathology: 8 core scientific courses (27 ECTS) and 1 language course (3 ECTS). The specialisation in immunology and immunopathology will be acquired through the 8 teaching units called: Innate immunity (3ECTS), Functional anatomy of the immune system (3ECTS), Antigen recognition (3ECTS), Receptor signalling (3ECTS), Mechanisms of immunopathology (3ECTS), Autoimmunity (3ECTS), Immunodeficiencies (3ECTS) and Immune response to pathogens (including HIV and Malaria) (6ECTS). Note that it is possible on this site to sign up for the course “Training course in laboratory animal science” in addition to the LIVE programme.
The LIVE students will be trained in Antwerp at semester 2 (S2) with a programme aligned with the students registered at the national master called “Leading International Vaccinology Education”. The S2 programme is composed of a second specialisation in infectiology: 3 core scientific courses (12 ECTS) and 1 course (3 ECTS) in advanced immunology, 3 courses (9 ECTS) in research & clinical vaccinology, 1 language course (3 ECTS) and 1 optional course (3 ECTS) to choose between languages or e-learning animal science. The specialisation in Infectiology will be acquired through the 3 teaching units called: Description & variability of pathogens (6 ECTS), Host-pathogen interactions (3 ECTS) and Clinical drug research (3ECTS). Advanced immunology will describe the specificities of the Immune system in new-borns, pregnant women and elderly (3 ECTS). The students will benefit from the skills of the GSK Belgian production site to start their knowledge in vaccinology with the teaching units: Novel technology, vaccine administration (3 ECTS) and vaccine manufacturing and quality control process (3 ECTS). Then they will participate to a high quality overview of vaccinology, during the summer school of vaccinology, yearly organized in Antwerp, before delving into details at the next semester. The 6 last ECTS are dedicated to train the students in languages and e-learning animal science for those who desire.
The LIVE students will be trained in Lyon-St Etienne at semester 3 (S3) with a programme aligned with the students registered at the national master called “Biologie Moléculaire et Cellulaire”. The S3 programme is composed of a specialisation in research and clinical vaccinology: 4 core scientific courses with 1 course of humanities around vaccinology (18 ECTS), and 1 course (3 ECTS) in infectiology, 1 course (3 ECTS) in advanced immunopathology, 1 courses of project management (3 ECTS) and 1 language course (3 ECTS). The specialisation in Vaccinology will be acquired through the 5 teaching units called: Vaccine formulation (3 ECTS), Clinical vaccine development (3 ECTS), Immunomonitoring of preclinical and clinical vaccine trials (3 ECTS), vaccine specific applications (3ECTS) and Communicating on vaccines & public health (6ECTS), a multidisciplinary teaching unit. Advanced immunology will describe the specificities of the Immune system in new-borns, pregnant women and elderly (3 ECTS). The students will benefit from the skills of the French Merial and Sanofi Pasteur sites in vaccinology to consolidate their knowledge in vaccinology. The 3 last ECTS are dedicated to train the students in languages. Note that it is possible on this site to run animal science course in addition to the LIVE programme.
The LIVE students will be trained in close collaboration between one of the main partner universities (Universitat Autònoma de Barcelona, Universitat de Barcelona, University of Antwerp, Université Lyon 1 Claude Bernard or Université Jean Monnet de St-Etienne) providing the academic tutor and the professional partner who will host the student for their internship and provide the professional tutor who belongs to an associated partner listed in the consortium agreement or another professional environment validated by the AMB. The programme is composed of a master thesis in vaccinology: evaluation will be subdivided into four parts for bibliography report (10%), professional laboratory work (10%), written thesis (40%) and oral defence (40%) to obtain 27 ECTS. Each national Master team will take care of the evaluation of one third of the students for evaluation of the bibliography report, the professional work and the master thesis, in agreement with standard coordinated organisation and guidelines (§4). The steering committee will organize a mini-symposium to conduct the oral defence evaluation with all main partners and involvement of associated partners who provide internship topics. The 3 last ECTS are dedicated to train the students in languages (standard or e-learning).
The LIVE programme is run by Université Lyon 1 Claude Bernard (Coordinating University in France), University Jean Monnet Saint-Etienne (France), University of Antwerp (Belgium), Universitat Autònoma de Barcelona (Spain) and Universitat de Barcelona (Spain). This master is an outstanding level academic programme in Vaccinology with a special emphasis on employability of the graduated international students, in agreement with our numerous international associated partners from the whole world of chain in Vaccinology: higher education institutions, foundations and other organisations around Vaccinology, research centres, small and medium size companies, big pharma companies and clinical centres in developed and developing countries. This diploma is designed for students who have done their undergraduate studies of at least 180 ECTS in the fields of medical or veterinary or life sciences. Students in the field of health (doctors, pharmacists, veterinarians) have access to full e-learning teaching units when they run mandatory health internships due to the constraints of their dual medical and scientific training. In agreement with the Bachelor, Master, Doctorate (BMD) diploma system in place in Europe, LIVE is composed of 4 semesters of 30 ECTS (European Credits Transfer System) each, for a total assessment of 120 ECTS.
The students will study at higher level a first specialisation in immunology and immunopathology in Barcelona, then a second specialisation in infectiology including microbiology, virology and host-pathogen interactions in Antwerp and a third specialisation in vaccinology in Lyon/ Saint-Etienne, to reach the level for doing a master thesis.